Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Colorcon
Boehringer Ingelheim
Mallinckrodt
Harvard Business School

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR GLUCOTROL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Glucotrol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00032474 ↗ Ginkgo Biloba Extract and the Insulin Resistance Syndrome Completed National Center for Complementary and Integrative Health (NCCIH) Phase 1/Phase 2 2001-12-01 The purpose of this study is to examine whether the ingestion of the herbal dietary supplement Ginkgo biloba extract has any effect on the efficacy of three classes of diabetic medications - (Glucotrol, Glucophage and Actose). Additionally, the study will examine the effect of Ginkgo biloba extract on pancreatic insulin production in non-diabetic subjects between the ages of 20 and 75 years old.
NCT00350779 ↗ Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) Completed Merck Sharp & Dohme Corp. Phase 3 2006-06-12 A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin/peroxisome proliferator-activated receptor gamma (PPARg) agonist combination therapy.
NCT00509236 ↗ Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) Completed Merck Sharp & Dohme Corp. Phase 3 2007-10-19 The purpose of the study is to compare sitagliptin and glipizide in lowering blood sugar in participants with type-2 diabetes mellitus (T2DM) and end-stage renal disease on dialysis who do not have adequate glycemic control.
NCT00509262 ↗ Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) Completed Merck Sharp & Dohme Corp. Phase 3 2007-10-09 The purpose of the study is to compare how sitagliptin and glipizide lower blood glucose levels in participants with moderate or severe renal insufficiency.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Glucotrol

Condition Name

Condition Name for Glucotrol
Intervention Trials
Type 2 Diabetes Mellitus 7
Type 2 Diabetes 2
Diabetes Mellitus, Type 2 2
Pharmacokinetic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Glucotrol
Intervention Trials
Diabetes Mellitus 12
Diabetes Mellitus, Type 2 11
Renal Insufficiency, Chronic 3
Kidney Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Glucotrol

Trials by Country

Trials by Country for Glucotrol
Location Trials
United States 60
India 17
Mexico 11
Italy 10
Hungary 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Glucotrol
Location Trials
Texas 5
Utah 3
Pennsylvania 3
Nebraska 3
California 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Glucotrol

Clinical Trial Phase

Clinical Trial Phase for Glucotrol
Clinical Trial Phase Trials
Phase 4 1
Phase 3 8
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Glucotrol
Clinical Trial Phase Trials
Completed 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Glucotrol

Sponsor Name

Sponsor Name for Glucotrol
Sponsor Trials
Merck Sharp & Dohme Corp. 5
Takeda 2
Baylor College of Medicine 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Glucotrol
Sponsor Trials
Industry 12
Other 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Moodys
Baxter
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.